CPEB3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.399700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.090200E-01
Normal-vs-Stage2
6.101600E-03
Normal-vs-Stage3
9.978700E-03
Normal-vs-Stage4
1.431810E-01
Stage1-vs-Stage2
7.919100E-03
Stage1-vs-Stage3
2.689800E-02
Stage1-vs-Stage4
3.888000E-01
Stage2-vs-Stage3
7.909700E-02
Stage2-vs-Stage4
3.936200E-01
Stage3-vs-Stage4
4.617600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.865900E-02
Normal-vs-AfricanAmerican
8.422000E-02
Normal-vs-Asian
2.007900E-02
Caucasian-vs-AfricanAmerican
6.489200E-01
Caucasian-vs-Asian
3.993400E-01
AfricanAmerican-vs-Asian
3.119200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.625590E-02
Normal-vs-Female
4.130000E-02
Male-vs-Female
9.659200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.029900E-02
Normal-vs-Age(41-60Yrs)
4.031800E-02
Normal-vs-Age(61-80Yrs)
2.424200E-02
Normal-vs-Age(81-100Yrs)
3.768100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.338200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.120600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.085600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.980600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.910200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.856350E-02
Normal-vs-Daily Drinker
3.684700E-03
Normal-vs-Weekly Drinker
2.812200E-02
Normal-vs-Occasional Drinker
2.620600E-01
Normal-vs-Social Drinker
1.081980E-01
Non Drinker-vs-Daily Drinker
3.270800E-01
Non Drinker-vs-Weekly Drinker
6.150800E-01
Non Drinker-vs-Occasional Drinker
5.761200E-01
Non Drinker-vs-Social Drinker
5.652600E-01
Daily Drinker-vs-Weekly Drinker
7.746000E-01
Daily Drinker-vs-Occasional Drinker
2.655000E-01
Daily Drinker-vs-Social Drinker
1.900400E-01
Weekly Drinker-vs-Occasional Drinker
4.349400E-01
Weekly Drinker-vs-Social Drinker
4.043800E-01
Occasional Drinker-vs-Social Drinker
9.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.479970E-01
Normal-vs-Grade 2
1.616440E-02
Normal-vs-Grade 3
2.703700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.827000E-01
Grade 1-vs-Grade 3
6.574800E-01
Grade 1-vs-Grade 4
1.479970E-01
Grade 2-vs-Grade 3
6.542200E-01
Grade 2-vs-Grade 4
1.616440E-02
Grade 3-vs-Grade 4
2.703700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.027870E-02
Normal-vs-NonDiabetic
1.940210E-02
Diabetic-vs-NonDiabetic
9.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.816060E-03
Normal-vs-NoPancreatitis
2.501800E-02
Pancreatitis-vs-NoPancreatitis
2.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.277190E-01
Normal-vs-N1
6.956800E-03
N0-vs-N1
3.123200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.214800E-01
Normal-vs-TP53-NonMutant
3.529200E-01
TP53-Mutant-vs-TP53-NonMutant
1.644310E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
